Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -97.39% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -85.68% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | 95.71% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -649.91% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | -11.17% |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | 12,688.80% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.17% |
| Mar 31, 2026 | -64.94% |
| Dec 31, 2025 | -23.57% |
| Sep 30, 2025 | -52.69% |
| Jun 30, 2025 | 4.71% |
| Mar 31, 2025 | 6.41% |
| Dec 31, 2024 | 23.08% |
| Sep 30, 2024 | 60.57% |
| Jun 30, 2024 | -37.38% |
| Mar 31, 2024 | -93.36% |
| Dec 31, 2023 | -92.03% |
| Sep 30, 2023 | -87.08% |
| Jun 30, 2023 | -83.62% |
| Mar 31, 2023 | 37.97% |
| Dec 31, 2022 | -50.37% |
| Sep 30, 2022 | -12.68% |
| Jun 30, 2022 | -49.08% |
| Mar 31, 2022 | -38.56% |
| Dec 31, 2021 | 341.24% |
| Sep 30, 2021 | 133.86% |